Insulin-like growth factor I receptor regulation in prostate carcinoma

Growth Hormone and IGF Research

Volumn 10, Issue SUPPL. A, 2000, Pages

  Roberts C T , Jr ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RNA; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

CANCER CELL; CANCER MODEL; CONFERENCE PAPER; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0033894546     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1096-6374(00)90009-1     Document Type: Conference Paper

References (9)

1. Evidence that insulin-like growth factor-I and growth hormone are required for prostate gland development
2. Systemic administration of insulin-like growth factor-I (IGF-I) causes growth of the rat prostate
3. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells
4. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
5. Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium
6. The insulin-like growth factor axis and prostate cancer: Lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model
7. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line
8. Reexpression of the type-1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells
9. Regulation of insulin-like-growth factor-I receptor promoter activity by wild-type and mutant versions of the WT 1 tumor suppressor